A prospective study was performed on 93 children admitted to Kasturba Medical College Hospital, Manipal and TMA Pai Rotary Hospital of Udupi and Karkala. Blood samples from 93 children admitted to the ward with no respiratory illness were taken as age-matched controls for the inpatients, IgM antibody against Mycoplasma pneumoniae was detected using a commercial kit (Virion-Serion ELISA, Germany) following the manufacturer's instructions. 23.96% of the inpatients with respiratory tract symptoms had IgM antibodies against Mycoplasma pneumoniae. The highest infection rate was found to be in the 2-5 and 5-10 year age group. The most common mode of presentation was an upper respiratory focus of infection with cervical lymphadenopathy. Bronchial breathing signifying pneumonic consolidation was significantly less in the Mycoplasma positive group ( p^0.006). There was no statistically significant difference in the radiological findings in the Mycoplasma positive and Mycoplasma negative groups.
Introduction
Mycoplasma pneumoniae, an important cause of upper and lower respiratory infection (LRI) in children, is resistant to B. lactum antibiotics that are frequently used in the treatment of LRI. 1 Estimates of the United Nations population division, place pneumonia as the first cause of death in children in developing countries. 2 From India, data on this infection are limited. A few recent studies show a high prevalence among children.
Clinical diagnoses of M. pneumoniae is difficult because of the simulating clinical picture of the viral and other pneumonias. Since its cultivation is very difficult and takes time. Laboratory results based on culture alone is of little use in planning chemotherapy for the patient. This has resulted in the development of rapid serological tests for detection of IgM antibodies as an accurate indicator of recent infection. 3, 4, 5 We used this test to determine the frequency of M. pneumoniae infection in children with selected acute respiratory infections.
Materials and Methods
Ninety-three previously healthy children, who presented with clinical features suggestive of acute respiratory infection of less than 4 weeks duration to the paediatrics department of Kasturba Hospital, Manipal and TMA Pai Rotary Hospital of Udupi and Karkala between the period March 2002 to November 2003 formed the subjects of the study. Children with history of recurrent wheezing, chronic lung disease, underlying immunodeficiency states or children with pre-existing cardiac, renal, neurological or hepatic dysfunction were excluded from the study. Blood samples from 93 children admitted in the ward with non-respiratory illness were taken as age matched controls for the inpatients. The mode of presentation and clinical findings were studied in all children. Radiological features were studied whenever obtained.
The sera was separated and stored at À20 C. IgM antibody against Mycoplasma pneumoniae were detected using a commercial kit (Virion-Serion ELISA Classic Mycoplasma pneumoniae, Germany) following the manufacturer's instructions.
Results
A total of 22 children of the 93 with acute respiratory infection had IgM antibody Mycoplasma pneumoniae. Antibody positivity was highest among the 2-5 and 5-10 year age group. It was the least below 2 years of age (Table 1) .
Among the children who tested positive for Mycoplasma pneumoniae IgM antibodies. 45.36 per cent had an upper respiratory focus of infection followed by consolidation (27.27 per cent) and wheezy bronchitis (22.72 per cent) ( Table 2) .
Cervical lymphadenopathy was the clinical finding which was found to be significantly higher in the Mycoplasma positive group ( p ¼ 0.006) ( Table 3 ). There was no statistically significant difference in the radiological findings between the two groups (Table 4) .
Discussion
A total of 22 children of the 93 with acute respiratory infection had IgM antibody against Mycoplasma pneumoniae giving a positivity of 23.96 per cent. None of the 93 children belonging to the control group in our study had IgM antibody against Mycoplasma pneumoniae. This difference among the cases and controls was statistically highly significant. Our study was in concordance with the study conducted by Elizabeth Mathai, et al. 5 and Usha Ramamurthy, et al. 6 who had positivity of 30.4 per cent and 31.5 per cent. Mycoplasma pneumoniae antibody positivity was the highest among the 2-5 and 5-10 years age group. It was the least below 2 years of age. This was significantly high compared with children in the 52 years age group ( p ¼ 0.465) and in children 410 year age group ( p ¼ 0.010). This has also been observed in the study by Usha Ramamurthy, et al. 6 and Waris Matti, et al. 7 who showed the highest positivity between 2-8 year age group. Study done by Grayston, et al. 8 which included the adult population also showed the highest prevalence in the 10-25 years age group and the least below 4 years of life. Among the children who tested positive for Mycoplasma pneumoniae IgM, 45.36 per cent had upper respiratory focus of infection followed by bronchopneumonia (27.27 per cent) and wheezy bronchitis (22.72 per cent). Two rare manifestations, in the form of intravascular haemolysis and acute gastroenteritis, were also seen in the present study. This is in contrast to the study by Elizabeth Mathai, et al. 5 in which wheeze associated respiratory infection (39.2 per cent) and pneumonia (39.2 per cent) were more common than pharyngitis (21.4 per cent). Feize, et al. 9 reported a similar pattern of illness in an epidemic outbreak of Mycoplasma pneumoniae infection in Scotland, in which 30 out of 40 patients studied had a predominantly upper respiratory focus of infection.
Fever, cough along with cervical lymphadenopathy was found to be more common among the Mycoplasma IgM-positive group ( p ¼ 0.06). Bronchial breathing was more common in the Mycoplasma-negative group (12.8 per cent) than the Mycoplasma positive group (4.5 per cent) p ¼ 0.009, suggesting indirectly that consolidation was less common in Mycoplasma pneumoniae infections. This study was in concordance with the There was no significant difference in the radiological findings between the two groups.
Conclusion
The present study indicates Mycoplasma pneumoniae play a significant role in community-acquired pneumonia in young children. Further studies are required to confirm these findings and to describe the spectrum of illness and seasonality of infection with this agent. 
